269 related articles for article (PubMed ID: 17226043)
1. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
[TBL] [Abstract][Full Text] [Related]
4. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone-associated biliary pseudolithiasis in children.
Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
[TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
Prince JS; Senac MO
Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
[TBL] [Abstract][Full Text] [Related]
7. Acute urine retention induced by ceftriaxone.
Akl KF; Masri AT; Hjazeen MM
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
[TBL] [Abstract][Full Text] [Related]
8. Research Progress of Mechanisms of Ceftriaxone Associated Nephrolithiasis.
Wang S; Huang X; Xu Q; Xu T
Mini Rev Med Chem; 2017; 17(17):1584-1587. PubMed ID: 27488586
[TBL] [Abstract][Full Text] [Related]
9. Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.
Bonnet JP; Abid L; Dabhar A; Lévy A; Soulier Y; Blangy S
Eur J Pediatr Surg; 2000 Dec; 10(6):368-71. PubMed ID: 11215777
[TBL] [Abstract][Full Text] [Related]
10. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study.
Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S
Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963
[TBL] [Abstract][Full Text] [Related]
11. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
Tasic V; Sofijanova A; Avramoski V
Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
[No Abstract] [Full Text] [Related]
12. Structure and elemental composition of Ceftriaxone induced pediatric nephrolithiasis.
Du Y; Kang M; Mena J; Stoller ML; Ho SP; Li J
Urolithiasis; 2021 Aug; 49(4):309-320. PubMed ID: 33587147
[TBL] [Abstract][Full Text] [Related]
13. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
[TBL] [Abstract][Full Text] [Related]
15. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
Murata S; Aomatsu T; Yoden A; Tamai H
Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis.
Kimata T; Kaneko K; Takahashi M; Hirabayashi M; Shimo T; Kino M
Pediatr Nephrol; 2012 Apr; 27(4):605-9. PubMed ID: 22038204
[TBL] [Abstract][Full Text] [Related]
17. Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months.
Bouissou F; Munzer C; Decramer S; Roussel B; Novo R; Morin D; Lavocat MP; Guyot C; Taque S; Fischbach M; Ouhayoun E; ; Loirat C;
Pediatrics; 2008 Mar; 121(3):e553-60. PubMed ID: 18267977
[TBL] [Abstract][Full Text] [Related]
18. Biliary precipitation during ceftriaxone therapy: frequency and risk factors.
Soysal A; Eraşov K; Akpinar I; Bakir M
Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742
[TBL] [Abstract][Full Text] [Related]
19. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
[TBL] [Abstract][Full Text] [Related]
20. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
